Home › Funds › Point72 Asset Management › ORMP
Point72 Asset Management position in ORMP
ORAMED PHARMACEUTICALS INC · Health Care
Latest position (Q1 2026)26.05K sh
Reported value held$88.58K
Portfolio Weight0.00%
First reportedQ4 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 25.44K | $72.51K | New |
| Q1 2026 | 26.05K | $88.58K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORMP
- BlackRock Inc 1.61M sh · $7.74M · Q2 2026
- Geode Capital Management 500.69K sh · $2.41M · Q2 2026
- Goldman Sachs Group 253.29K sh · $1.22M · Q2 2026
- Northern Trust Corp 184.92K sh · $889.47K · Q2 2026
- Renaissance Technologies 183.80K sh · $884.08K · Q2 2026
- Wells Fargo & Co 166.00K sh · $798.46K · Q2 2026
- Bank of America Corp 150.69K sh · $724.84K · Q2 2026
- Marshall Wace 101.95K sh · $490.39K · Q2 2026
- Charles Schwab Investment Management 83.63K sh · $402.28K · Q2 2026
- BNY Mellon 79.25K sh · $381.22K · Q2 2026
- UBS Group AG 67.67K sh · $325.50K · Q2 2026
- Morgan Stanley 43.36K sh · $208.55K · Q2 2026